We’re pleased to announce that the 2020 QA & Dosimetry Symposium (QADS12) preliminary program is now available. Over the course of two days, industry experts will present 24 talks across four timely sessions:
- Safety & Independent QA in Radiation Oncology
- Stereotactic Treatment & QA
- Advancements in Planning & QA
- Emergent Modalities & QA Considerations
Presentations will address innovation in Machine Learning and AI, trends in safety and open data access, and developments for efficient stereotactic and new modality Quality Assurance.
QADS12 is set for February 21-22, 2020, at the Gaylord Palms Resort and Convention Center in Orlando, Florida. CE credits to be applied for include SAM, MPCEC credit hours via CAMPEP, and MDCB credits.
Stay tuned for speaker announcements, but don't wait too long to register. Early bird savings expire December 16, 2019. Join us for two days of continuing education, endorsed by the AAPM*.
“Sun Nuclear does a great job selecting interesting and well-balanced topics for QADS. Having similar talks grouped together, with breaks in-between, was a great way to organize the meeting and keep attendees focused.”
- Diego Jurado-Bruggeman, M.S., QADS11 attendee
About the QA & Dosimetry Symposium
Hosted by Sun Nuclear, the QA & Dosimetry Symposium (QADS) is the premier Radiation Oncology educational event focused exclusively on strategies for continuous improvements in Quality and Patient Safety. The intimate event is held biennially and welcomes 200+ participants from around the world.
*AAPM does not endorse the product in question: rather, it endorsed the educational component of the program